Olive Oil for Heart Failure
(OLEA-HF Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
The OLEA-HF study aims to explore whether daily supplementation of extra-virgin olive oil (EVOO) for 12 weeks during participation in a cardiac rehabilitation program (standard of care) is feasible in patients with heart failure with reduced ejection fraction (HFrEF). The investigators will also determine the effects of EVOO on functional capacity and quality of life.
Who Is on the Research Team?
Salvatore Carbone, PhD, RDN
Principal Investigator
Macon & Joan Brock Virginia Health Sciences at Old Dominion University
Are You a Good Fit for This Trial?
This trial is for adults diagnosed with heart failure with reduced ejection fraction (a type of weakened heart muscle). Participants should be able to join a cardiac rehab program. Specific inclusion and exclusion details are not listed here.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive daily supplementation of extra-virgin olive oil (EVOO) for 12 weeks during participation in a cardiac rehabilitation program
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Trial Overview
The study tests if taking extra-virgin olive oil daily for 12 weeks, along with standard cardiac rehabilitation, helps people with this kind of heart failure. The main focus is on safety, feasibility, and effects on fitness and quality of life.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Cardiac rehabilitation as part of standard of care
Find a Clinic Near You
Who Is Running the Clinical Trial?
Old Dominion University
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.